MCM6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.107800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.833800E-01
Normal-vs-Stage2
6.389800E-01
Normal-vs-Stage3
9.325800E-01
Normal-vs-Stage4
9.588400E-01
Stage1-vs-Stage2
2.505200E-01
Stage1-vs-Stage3
7.529200E-01
Stage1-vs-Stage4
6.532400E-01
Stage2-vs-Stage3
5.236400E-01
Stage2-vs-Stage4
5.588800E-01
Stage3-vs-Stage4
9.514800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.025400E-01
Normal-vs-AfricanAmerican
4.212000E-01
Normal-vs-Asian
7.275200E-01
Caucasian-vs-AfricanAmerican
8.027200E-01
Caucasian-vs-Asian
6.565800E-02
AfricanAmerican-vs-Asian
1.022560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.382600E-01
Normal-vs-Female
5.917200E-01
Male-vs-Female
1.108430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.306800E-01
Normal-vs-Age(41-60Yrs)
5.770000E-01
Normal-vs-Age(61-80Yrs)
7.995200E-01
Normal-vs-Age(81-100Yrs)
5.290400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.768820E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.792570E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.738400E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.525030E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.132600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.076600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.057800E-01
Normal-vs-Daily Drinker
9.833400E-01
Normal-vs-Weekly Drinker
5.651600E-01
Normal-vs-Occasional Drinker
6.683200E-01
Normal-vs-Social Drinker
6.846200E-01
Non Drinker-vs-Daily Drinker
5.489400E-01
Non Drinker-vs-Weekly Drinker
3.320000E-01
Non Drinker-vs-Occasional Drinker
6.172400E-01
Non Drinker-vs-Social Drinker
6.582000E-01
Daily Drinker-vs-Weekly Drinker
2.221800E-01
Daily Drinker-vs-Occasional Drinker
3.199400E-01
Daily Drinker-vs-Social Drinker
3.556400E-01
Weekly Drinker-vs-Occasional Drinker
4.976800E-01
Weekly Drinker-vs-Social Drinker
4.961000E-01
Occasional Drinker-vs-Social Drinker
9.798600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.120800E-01
Normal-vs-Grade 2
6.622800E-01
Normal-vs-Grade 3
6.765000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.024500E-03
Grade 1-vs-Grade 3
4.499300E-03
Grade 1-vs-Grade 4
6.120800E-01
Grade 2-vs-Grade 3
3.785800E-01
Grade 2-vs-Grade 4
6.622800E-01
Grade 3-vs-Grade 4
6.765000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.935600E-01
Normal-vs-NonDiabetic
7.318200E-01
Diabetic-vs-NonDiabetic
7.828200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.714400E-01
Normal-vs-NoPancreatitis
7.327000E-01
Pancreatitis-vs-NoPancreatitis
4.150400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.809600E-01
Normal-vs-N1
6.385800E-01
N0-vs-N1
4.441600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.651000E-01
Normal-vs-TP53-NonMutant
9.211600E-01
TP53-Mutant-vs-TP53-NonMutant
1.477880E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
